Cardiovascular Medicine Faculty
Dmitri Baklanov, M.D., Ph.D.
Assistant Professor of MedicineDr. Baklanov's primary areas of interest are Cell and Gene Therapy for Cardiovascular Disease, High Risk Endovascular Intervention
Board Certifications
- Internal Medicine
- Vascular Medicine
- Nuclear Cardiology
- Echocardiography
- Cardiovascular Disease
- Interventional Cardiology
Honors & Organizations:
- American Heart Association Council on Atherosclerosis, Thrombosis and Vascular Biology
- Society for Cardiovascular Angiography and Interventions
- Society for Vascular Medicine
Medical School
St. Petersburg Pavlov Medical UniversitySt. Petersburg, Russia
Residency
Yale University School of MedicineNew Haven, Connecticut
Fellowship, Interventional Cardiology
Jewish HospitalLouisville, Kentucky
Fellowship Cardiovascular Disease
Dartmouth-Hitchcock Medical CenterLebanon, New Hampshire
Fellowship Cardiovascular Disease
Dartmouth-Hitchcock Medical CenterLebanon, New Hampshire
Publications:
- Baklanov DV, DeMuinck ED, Simons M, Moodie KL, Arbuckle BE, Thompson CA, Palac RT. Live 3D Echo Guidance of catheter-based endomyocardial injection. Cathet Cardiovasc Intervention 2005; 65:340-345
- Baklanov DV, Marcu CB, Juhasz DF, Caracciolo EA, Chawarski MC, Donohue TJ. Coronary stenting is safe and effective in a high risk octogenarian patient cohort. Connecticut Medicine 2006; 70(1):15-20
- Mandinov L ,Moodie K, Mandinova A, Zhuang Z, Redican F, Baklanov D, Lindner V, Maciag T, Simons M, de Muinck E. Inhibition of in-stent restenosis by oral copper chelation in porcine coronary arteries. Am J Physiol Heart Circ Physiol (May 26, 2006). doi:10.1152/ajpheart.00148.2006
